Research progress of azido-containing Pt(IV) antitumor compounds

Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2022-01, Vol.227, p.113927-113927, Article 113927
Hauptverfasser: Mu, Meilin, Zhan, Jiuyu, Dai, Xiaohan, Gao, Hongwei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113927
container_issue
container_start_page 113927
container_title European journal of medicinal chemistry
container_volume 227
creator Mu, Meilin
Zhan, Jiuyu
Dai, Xiaohan
Gao, Hongwei
description Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs. [Display omitted] •New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.
doi_str_mv 10.1016/j.ejmech.2021.113927
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2586504030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523421007765</els_id><sourcerecordid>2586504030</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EglL4A4SyLIsUP2I73SAQ4lEJCYSAreXHpLhq4mInSPD1pEphyWo2586dOQidEDwlmIjz5RSWNdj3KcWUTAlhMyp30IhIUeaM8mIXjTClLOeUFQfoMKUlxpgLjPfRASvEjEvJR-jyGRLoaN-zdQyLCCllocr0t3cht6FptW98s8ie2sn87SzTTevbrg4xs6Feh65x6QjtVXqV4Hg7x-j19ubl-j5_eLybX1895JYJ2uakAiM5N8RQUZQFA2wqq-XMlDMqJJfOMs2LSpbM6IoTI4hx2BhunATiBGdjNBn29nd-dJBaVftkYbXSDYQuKcpLwXGBGe7RYkBtDClFqNQ6-lrHL0Ww2rhTSzW4Uxt3anDXx063DZ2pwf2FfmX1wMUAQP_np4eokvXQWHA-gm2VC_7_hh_WOoFP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586504030</pqid></control><display><type>article</type><title>Research progress of azido-containing Pt(IV) antitumor compounds</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mu, Meilin ; Zhan, Jiuyu ; Dai, Xiaohan ; Gao, Hongwei</creator><creatorcontrib>Mu, Meilin ; Zhan, Jiuyu ; Dai, Xiaohan ; Gao, Hongwei</creatorcontrib><description>Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs. [Display omitted] •New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2021.113927</identifier><identifier>PMID: 34695775</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Anticancer ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Azides - chemistry ; Azides - pharmacology ; Cell Proliferation - drug effects ; Diazido ; Drug Development ; Humans ; Neoplasms - drug therapy ; Neoplasms - pathology ; Organoplatinum Compounds - chemistry ; Organoplatinum Compounds - pharmacology ; Photoactivation ; Prodrugs ; Pt(IV)</subject><ispartof>European journal of medicinal chemistry, 2022-01, Vol.227, p.113927-113927, Article 113927</ispartof><rights>2021 Elsevier Masson SAS</rights><rights>Copyright © 2021 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</citedby><cites>FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0223523421007765$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34695775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mu, Meilin</creatorcontrib><creatorcontrib>Zhan, Jiuyu</creatorcontrib><creatorcontrib>Dai, Xiaohan</creatorcontrib><creatorcontrib>Gao, Hongwei</creatorcontrib><title>Research progress of azido-containing Pt(IV) antitumor compounds</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs. [Display omitted] •New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.</description><subject>Anticancer</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Azides - chemistry</subject><subject>Azides - pharmacology</subject><subject>Cell Proliferation - drug effects</subject><subject>Diazido</subject><subject>Drug Development</subject><subject>Humans</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - pathology</subject><subject>Organoplatinum Compounds - chemistry</subject><subject>Organoplatinum Compounds - pharmacology</subject><subject>Photoactivation</subject><subject>Prodrugs</subject><subject>Pt(IV)</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EglL4A4SyLIsUP2I73SAQ4lEJCYSAreXHpLhq4mInSPD1pEphyWo2586dOQidEDwlmIjz5RSWNdj3KcWUTAlhMyp30IhIUeaM8mIXjTClLOeUFQfoMKUlxpgLjPfRASvEjEvJR-jyGRLoaN-zdQyLCCllocr0t3cht6FptW98s8ie2sn87SzTTevbrg4xs6Feh65x6QjtVXqV4Hg7x-j19ubl-j5_eLybX1895JYJ2uakAiM5N8RQUZQFA2wqq-XMlDMqJJfOMs2LSpbM6IoTI4hx2BhunATiBGdjNBn29nd-dJBaVftkYbXSDYQuKcpLwXGBGe7RYkBtDClFqNQ6-lrHL0Ww2rhTSzW4Uxt3anDXx063DZ2pwf2FfmX1wMUAQP_np4eokvXQWHA-gm2VC_7_hh_WOoFP</recordid><startdate>20220105</startdate><enddate>20220105</enddate><creator>Mu, Meilin</creator><creator>Zhan, Jiuyu</creator><creator>Dai, Xiaohan</creator><creator>Gao, Hongwei</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220105</creationdate><title>Research progress of azido-containing Pt(IV) antitumor compounds</title><author>Mu, Meilin ; Zhan, Jiuyu ; Dai, Xiaohan ; Gao, Hongwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticancer</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Azides - chemistry</topic><topic>Azides - pharmacology</topic><topic>Cell Proliferation - drug effects</topic><topic>Diazido</topic><topic>Drug Development</topic><topic>Humans</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - pathology</topic><topic>Organoplatinum Compounds - chemistry</topic><topic>Organoplatinum Compounds - pharmacology</topic><topic>Photoactivation</topic><topic>Prodrugs</topic><topic>Pt(IV)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mu, Meilin</creatorcontrib><creatorcontrib>Zhan, Jiuyu</creatorcontrib><creatorcontrib>Dai, Xiaohan</creatorcontrib><creatorcontrib>Gao, Hongwei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mu, Meilin</au><au>Zhan, Jiuyu</au><au>Dai, Xiaohan</au><au>Gao, Hongwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research progress of azido-containing Pt(IV) antitumor compounds</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2022-01-05</date><risdate>2022</risdate><volume>227</volume><spage>113927</spage><epage>113927</epage><pages>113927-113927</pages><artnum>113927</artnum><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs. [Display omitted] •New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>34695775</pmid><doi>10.1016/j.ejmech.2021.113927</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2022-01, Vol.227, p.113927-113927, Article 113927
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_2586504030
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anticancer
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Azides - chemistry
Azides - pharmacology
Cell Proliferation - drug effects
Diazido
Drug Development
Humans
Neoplasms - drug therapy
Neoplasms - pathology
Organoplatinum Compounds - chemistry
Organoplatinum Compounds - pharmacology
Photoactivation
Prodrugs
Pt(IV)
title Research progress of azido-containing Pt(IV) antitumor compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T21%3A46%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20progress%20of%20azido-containing%20Pt(IV)%20antitumor%20compounds&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Mu,%20Meilin&rft.date=2022-01-05&rft.volume=227&rft.spage=113927&rft.epage=113927&rft.pages=113927-113927&rft.artnum=113927&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2021.113927&rft_dat=%3Cproquest_cross%3E2586504030%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2586504030&rft_id=info:pmid/34695775&rft_els_id=S0223523421007765&rfr_iscdi=true